View Future GrowthHUMAN TECHNOLOGY 過去の業績過去 基準チェック /06HUMAN TECHNOLOGYの収益は年間平均-22.1%の割合で減少していますが、 Communications業界の収益は年間 減少しています。収益は年間5.1% 1.1%割合で 増加しています。主要情報-22.06%収益成長率23.55%EPS成長率Communications 業界の成長16.35%収益成長率1.07%株主資本利益率-44.62%ネット・マージン-32.98%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 26Full year 2022 earnings released: ₩1,245 loss per share (vs ₩1,199 loss in FY 2021)Full year 2022 results: ₩1,245 loss per share (further deteriorated from ₩1,199 loss in FY 2021). Revenue: ₩35.5b (down 24% from FY 2021). Net loss: ₩10.3b (loss widened 66% from FY 2021). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.すべての更新を表示Recent updatesお知らせ • Mar 17HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 31, 2026HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 5, hwangsaeul-ro 335beon-gil, bundang-g, gyeonggi-do, seongnam South Korea分析記事 • Feb 02HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) Share Price Not Quite Adding UpWhen close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...分析記事 • Dec 22Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Debt Sensibly?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Aug 23Risks Still Elevated At These Prices As HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shares Dive 29%HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...分析記事 • Jun 16What HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) 25% Share Price Gain Is Not Telling YouHUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shares have had a really impressive month, gaining 25% after a shaky period...分析記事 • Jun 13Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...New Risk • Jun 02New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩9.8b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩9.8b free cash flow). Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩126.5b market cap, or US$91.9m).New Risk • Apr 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩114.4b market cap, or US$79.8m).分析記事 • Apr 06Some HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shareholders Look For Exit As Shares Take 25% PoundingHUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...お知らせ • Mar 14HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 28, 2025HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 131, bungdangnaegok-ro, bungdang-gu, gyeonggi-do, seongnam South Koreaお知らせ • Mar 05HUMAN TECHNOLOGY Co., Ltd announced that it has received KRW 11.7259845 billion in fundingOn March 4, 2025, HUMAN TECHNOLOGY Co., Ltd closed the transaction,お知らせ • Feb 20HUMAN TECHNOLOGY Co., Ltd announced that it expects to receive KRW 11.7259845 billion in fundingHUMAN TECHNOLOGY Co., Ltd announced a private placement to issue 2,112,790 shares at an issue price of KRW 5,550 for gross proceeds of KRW 11,725,984,500 on February 19, 2025. The transaction will include participation from new individual investors Moon Sungwon 1,038,721 shares, Kim Jongseop 852,105 shares, Cho Manjin 24,662 shares, Ryu Jongmun 98,651 shares and Son Byung-kwan 98,651 shares. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on February 28, 2025.分析記事 • Jan 24HUMAN TECHNOLOGY (KOSDAQ:175140) Is Using Debt SafelyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 12% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩105.9b market cap, or US$72.6m).分析記事 • Nov 27Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) With Shares Advancing 25%HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders are no doubt pleased to see that the share price has bounced...分析記事 • Oct 15HUMAN TECHNOLOGY (KOSDAQ:175140) Has Debt But No Earnings; Should You Worry?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Aug 06Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) PriceWhen close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...お知らせ • Mar 13+ 1 more updateINFOMARK Co., Ltd announced that it has received KRW 16.10000146 billion in fundingOn March 11, 2024, INFOMARK Co., Ltd closed the transaction. The company announced that the transaction included participation from new investor, Human Tech Association for 5,127,389 shares and had an ownership ration of 23.83% in the company.お知らせ • Mar 12INFOMARK Co., Ltd (KOSDAQ:A175140) completed the acquisition of KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940).INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion on March 4, 2024.INFOMARK Co., Ltd (KOSDAQ:A175140) completed the acquisition of KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) on March 11, 2024.お知らせ • Mar 06INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion.INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion on March 4, 2024.お知らせ • Jan 18INFOMARK Co., Ltd announced that it expects to receive KRW 9 billion in funding from Tm Asset Management Co., Ltd., F&F Co., Ltd and another investorINFOMARK Co., Ltd announced a private placement to issue Series 9 Non-guaranteed private placement convertible bonds with bearer interest for the gross proceeds of KRW 9,000,000,000 on January 17, 2024. The transaction will include participation from new investors F&F Co., Ltd. for KRW 2,000,000,000, Elim Corporation Co., Ltd. for KRW 2,000,000,000 and TM Asset Management Co., Ltd. for KRW 5,000,000,000. The transaction has been approved by the shareholders of the company and is expected to close on February 21, 2024. The bonds are 100% convertible into 2,112,180 shares at a fixed conversion price of KRW 4,261 from February 21, 2025 to January 21, 2027. The bonds bear 4% coupon rate and 5% maturity rate and matures on February 21, 2027. The securities are restricted to a hold period of 1 year.New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (87% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩72.6b market cap, or US$55.4m).New Risk • Nov 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩102.9b (US$78.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (87% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩102.9b market cap, or US$78.1m).New Risk • Jul 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩27b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩27b free cash flow). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (68% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change).New Risk • Jul 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (68% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).お知らせ • Jun 09INFOMARK Co., Ltd announced that it expects to receive KRW 14.99999852 billion in funding from Tdi PartnershipINFOMARK Co., Ltd announced a private placement to issue 2,071,823 common shares at an issue price of KRW 7,240 per share for the gross proceeds of KRW 14,999,998,520 on June 7, 2023. The transaction will include participation from new investor Tdi Partnership. The transaction has been approved by the shareholders of the company and is expected to close on July 19, 2023. The shares are restricted to a hold period of one year.Reported Earnings • Mar 26Full year 2022 earnings released: ₩1,245 loss per share (vs ₩1,199 loss in FY 2021)Full year 2022 results: ₩1,245 loss per share (further deteriorated from ₩1,199 loss in FY 2021). Revenue: ₩35.5b (down 24% from FY 2021). Net loss: ₩10.3b (loss widened 66% from FY 2021). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.お知らせ • Jan 13INFOMARK Co., Ltd announced that it expects to receive KRW 3.00000291 billion in funding from TDI Co., Ltd.INFOMARK Co., Ltd announced a private placement of 601,806 common shares at an issue price of KRW 4,985 per share for proceeds of KRW 3,000,002,910 on January 12, 2023. The transaction will include participation from TDI Co., Ltd. The securities will be issued pursuant to 3rd party allotment method. The transaction has been approved by the board of directors of the company. The transaction is expected to close on January 20, 2023. The securities will be subject to a hold period of 1 year.お知らせ • Aug 19INFOMARK Co., Ltd announced that it has received KRW 6.6 billion in fundingOn August 18, 2022, INFOMARK Co., Ltd closed the transaction.お知らせ • Jun 22INFOMARK Co., Ltd announced that it has received KRW 8 billion in fundingOn June 20, 2022, INFOMARK Co., Ltd closed the transaction.Is New 90 Day High Low • Feb 17New 90-day high: ₩11,200The company is up 85% from its price of ₩6,070 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 13% over the same period.Is New 90 Day High Low • Jan 11New 90-day high: ₩8,580The company is up 42% from its price of ₩6,040 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 7.0% over the same period.分析記事 • Dec 24Does Infomark (KOSDAQ:175140) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is New 90 Day High Low • Dec 21New 90-day high: ₩7,560The company is up 29% from its price of ₩5,860 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is flat over the same period.Is New 90 Day High Low • Dec 03New 90-day high: ₩6,370The company is up 6.0% from its price of ₩6,000 on 04 September 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Communications industry, which is down 8.0% over the same period.Is New 90 Day High Low • Sep 25New 90-day low: ₩5,470The company is down 6.0% from its price of ₩5,850 on 26 June 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 16% over the same period.収支内訳HUMAN TECHNOLOGY の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A175140 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Dec 2555,491-18,30017,13872830 Sep 2549,307-24,87516,1811,36830 Jun 2550,977-22,13115,35596331 Mar 2548,691-16,84411,92456231 Dec 2442,683-15,97611,64143630 Sep 2447,697-16,47415,34166130 Jun 2442,140-16,12314,18977431 Mar 2439,141-14,56311,34673331 Dec 2338,503-14,1709,1661,18230 Sep 2328,876-3,0953,9391,25930 Jun 2328,355-6,6364,0352,01531 Mar 2335,005-7,7267,4542,16631 Dec 2235,537-10,2517,6522,24630 Sep 2242,270-14,5379,1931,91530 Jun 2242,876-11,2027,6811,44031 Mar 2242,309-10,0467,4921,80531 Dec 2146,673-6,1607,5462,04830 Sep 2150,588-7,9326,2802,73430 Jun 2152,697-7,6906,6792,78031 Mar 2148,638-6,1345,9062,38331 Dec 2043,506-11,3526,8402,40530 Sep 2063,411-9,8869,2582,28230 Jun 2067,790-6,2479,8572,55931 Mar 2069,866-12,20511,3323,01931 Dec 1975,225-10,61011,6482,77130 Sep 1963,180-3,08011,1392,70030 Jun 1963,191-8,54410,9122,32931 Mar 1992,917-3,93510,5762,15031 Dec 18118,47912411,1762,27730 Sep 18115,250-4,53711,2012,65630 Jun 18102,772-5,94111,4222,91231 Mar 1875,858-6,94411,5663,07631 Dec 1756,416-7,19513,0623,05030 Sep 1749,206-4,09313,1832,93931 Dec 1663,6661,08313,3212,086質の高い収益: A175140は現在利益が出ていません。利益率の向上: A175140は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A175140は利益が出ておらず、過去 5 年間で損失は年間22.1%の割合で増加しています。成長の加速: A175140の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: A175140は利益が出ていないため、過去 1 年間の収益成長をCommunications業界 ( -13.9% ) と比較することは困難です。株主資本利益率高いROE: A175140は現在利益が出ていないため、自己資本利益率 ( -44.62% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YTech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 22:02終値2026/05/20 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HUMAN TECHNOLOGY Co., Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Jongsun ParkEugene Investment & Securities Co Ltd.Juho YoonYuanta Securities Korea Co., Ltd.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩1,245 loss per share (vs ₩1,199 loss in FY 2021)Full year 2022 results: ₩1,245 loss per share (further deteriorated from ₩1,199 loss in FY 2021). Revenue: ₩35.5b (down 24% from FY 2021). Net loss: ₩10.3b (loss widened 66% from FY 2021). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.
お知らせ • Mar 17HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 31, 2026HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 5, hwangsaeul-ro 335beon-gil, bundang-g, gyeonggi-do, seongnam South Korea
分析記事 • Feb 02HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) Share Price Not Quite Adding UpWhen close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...
分析記事 • Dec 22Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Debt Sensibly?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Aug 23Risks Still Elevated At These Prices As HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shares Dive 29%HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...
分析記事 • Jun 16What HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) 25% Share Price Gain Is Not Telling YouHUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shares have had a really impressive month, gaining 25% after a shaky period...
分析記事 • Jun 13Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
New Risk • Jun 02New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩9.8b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩9.8b free cash flow). Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩126.5b market cap, or US$91.9m).
New Risk • Apr 24New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 11% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (₩114.4b market cap, or US$79.8m).
分析記事 • Apr 06Some HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shareholders Look For Exit As Shares Take 25% PoundingHUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...
お知らせ • Mar 14HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 28, 2025HUMAN TECHNOLOGY Co., Ltd, Annual General Meeting, Mar 28, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 131, bungdangnaegok-ro, bungdang-gu, gyeonggi-do, seongnam South Korea
お知らせ • Mar 05HUMAN TECHNOLOGY Co., Ltd announced that it has received KRW 11.7259845 billion in fundingOn March 4, 2025, HUMAN TECHNOLOGY Co., Ltd closed the transaction,
お知らせ • Feb 20HUMAN TECHNOLOGY Co., Ltd announced that it expects to receive KRW 11.7259845 billion in fundingHUMAN TECHNOLOGY Co., Ltd announced a private placement to issue 2,112,790 shares at an issue price of KRW 5,550 for gross proceeds of KRW 11,725,984,500 on February 19, 2025. The transaction will include participation from new individual investors Moon Sungwon 1,038,721 shares, Kim Jongseop 852,105 shares, Cho Manjin 24,662 shares, Ryu Jongmun 98,651 shares and Son Byung-kwan 98,651 shares. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on February 28, 2025.
分析記事 • Jan 24HUMAN TECHNOLOGY (KOSDAQ:175140) Is Using Debt SafelyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 12% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩105.9b market cap, or US$72.6m).
分析記事 • Nov 27Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) With Shares Advancing 25%HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders are no doubt pleased to see that the share price has bounced...
分析記事 • Oct 15HUMAN TECHNOLOGY (KOSDAQ:175140) Has Debt But No Earnings; Should You Worry?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Aug 06Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) PriceWhen close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...
お知らせ • Mar 13+ 1 more updateINFOMARK Co., Ltd announced that it has received KRW 16.10000146 billion in fundingOn March 11, 2024, INFOMARK Co., Ltd closed the transaction. The company announced that the transaction included participation from new investor, Human Tech Association for 5,127,389 shares and had an ownership ration of 23.83% in the company.
お知らせ • Mar 12INFOMARK Co., Ltd (KOSDAQ:A175140) completed the acquisition of KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940).INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion on March 4, 2024.INFOMARK Co., Ltd (KOSDAQ:A175140) completed the acquisition of KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) on March 11, 2024.
お知らせ • Mar 06INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion.INFOMARK Co., Ltd (KOSDAQ:A175140) agreed to acquire KWAVE Co.,Ltd. from Quantapia Inc. (KOSDAQ:A078940) for KRW7 billion on March 4, 2024.
お知らせ • Jan 18INFOMARK Co., Ltd announced that it expects to receive KRW 9 billion in funding from Tm Asset Management Co., Ltd., F&F Co., Ltd and another investorINFOMARK Co., Ltd announced a private placement to issue Series 9 Non-guaranteed private placement convertible bonds with bearer interest for the gross proceeds of KRW 9,000,000,000 on January 17, 2024. The transaction will include participation from new investors F&F Co., Ltd. for KRW 2,000,000,000, Elim Corporation Co., Ltd. for KRW 2,000,000,000 and TM Asset Management Co., Ltd. for KRW 5,000,000,000. The transaction has been approved by the shareholders of the company and is expected to close on February 21, 2024. The bonds are 100% convertible into 2,112,180 shares at a fixed conversion price of KRW 4,261 from February 21, 2025 to January 21, 2027. The bonds bear 4% coupon rate and 5% maturity rate and matures on February 21, 2027. The securities are restricted to a hold period of 1 year.
New Risk • Nov 07New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (87% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩72.6b market cap, or US$55.4m).
New Risk • Nov 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩102.9b (US$78.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (87% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩102.9b market cap, or US$78.1m).
New Risk • Jul 21New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩27b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₩27b free cash flow). Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (68% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change).
New Risk • Jul 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (68% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).
お知らせ • Jun 09INFOMARK Co., Ltd announced that it expects to receive KRW 14.99999852 billion in funding from Tdi PartnershipINFOMARK Co., Ltd announced a private placement to issue 2,071,823 common shares at an issue price of KRW 7,240 per share for the gross proceeds of KRW 14,999,998,520 on June 7, 2023. The transaction will include participation from new investor Tdi Partnership. The transaction has been approved by the shareholders of the company and is expected to close on July 19, 2023. The shares are restricted to a hold period of one year.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩1,245 loss per share (vs ₩1,199 loss in FY 2021)Full year 2022 results: ₩1,245 loss per share (further deteriorated from ₩1,199 loss in FY 2021). Revenue: ₩35.5b (down 24% from FY 2021). Net loss: ₩10.3b (loss widened 66% from FY 2021). Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.
お知らせ • Jan 13INFOMARK Co., Ltd announced that it expects to receive KRW 3.00000291 billion in funding from TDI Co., Ltd.INFOMARK Co., Ltd announced a private placement of 601,806 common shares at an issue price of KRW 4,985 per share for proceeds of KRW 3,000,002,910 on January 12, 2023. The transaction will include participation from TDI Co., Ltd. The securities will be issued pursuant to 3rd party allotment method. The transaction has been approved by the board of directors of the company. The transaction is expected to close on January 20, 2023. The securities will be subject to a hold period of 1 year.
お知らせ • Aug 19INFOMARK Co., Ltd announced that it has received KRW 6.6 billion in fundingOn August 18, 2022, INFOMARK Co., Ltd closed the transaction.
お知らせ • Jun 22INFOMARK Co., Ltd announced that it has received KRW 8 billion in fundingOn June 20, 2022, INFOMARK Co., Ltd closed the transaction.
Is New 90 Day High Low • Feb 17New 90-day high: ₩11,200The company is up 85% from its price of ₩6,070 on 19 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 13% over the same period.
Is New 90 Day High Low • Jan 11New 90-day high: ₩8,580The company is up 42% from its price of ₩6,040 on 13 October 2020. The South Korean market is up 29% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is up 7.0% over the same period.
分析記事 • Dec 24Does Infomark (KOSDAQ:175140) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Is New 90 Day High Low • Dec 21New 90-day high: ₩7,560The company is up 29% from its price of ₩5,860 on 22 September 2020. The South Korean market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Communications industry, which is flat over the same period.
Is New 90 Day High Low • Dec 03New 90-day high: ₩6,370The company is up 6.0% from its price of ₩6,000 on 04 September 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Communications industry, which is down 8.0% over the same period.
Is New 90 Day High Low • Sep 25New 90-day low: ₩5,470The company is down 6.0% from its price of ₩5,850 on 26 June 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Communications industry, which is up 16% over the same period.